Indications and uses
• helps prevent sunburn • higher SPF gives more sunburn protection • helps protect the skin against the harmful effects of UVA and UVB rays • retains SPF after 80 minutes of activity in the water or sweating
• helps prevent sunburn • higher SPF gives more sunburn protection • helps protect the skin against the harmful effects of UVA and UVB rays • retains SPF after 80 minutes of activity in the water or sweating
• apply generously and evenly to all exposed areas before sun exposure • reapply as needed or after towel drying, swimming, perspiring or vigorous activity • children under 6 months of age: ask a doctor
Active Ingredients Purpose
Avobenzone 2.0%, Octinoxate 7.5%,
Octisalate 5.0%, Oxybenzone 4.0% .................. Sunscreen
• helps prevent sunburn • higher SPF gives more
sunburn protection • helps protect the skin against the
harmful effects of UVA and UVB rays • retains SPF after
80 minutes of activity in the water or sweating
For external use only
avoid contact with the eyes.
If contact occurs rinse thoroughly with water.
rash or irritation develops
and lasts.
If swallowed, get medical
help or contact a Poison Control Center immediately.
• apply generously and evenly to all exposed areas before
sun exposure • reapply as needed or after towel drying,
swimming, perspiring or vigorous activity • children
under 6 months of age: ask a doctor
• may stain some fabrics
• Sun alert: Limiting sun exposure, wearing protective
clothing, and using sunscreens may reduce the risks of skin
aging, skin cancer, and other harmful effects of the sun.
Acrylates / C10-30 Alkyl
Acrylate Crosspolymer, Butylparaben, Chlorophenesin,
Disodium EDTA, Ethylparaben, Fragrance, Glyceryl
Stearate, Green Tea (Camellia Sinensis) Leaf Extract,
Iodopropynyl Butylcarbamate, Isopropyl Myristate,
Methylparaben, Phenoxyethanol, Polyethylene,
Potassium Cetyl Phosphate, Propylene Glycol,
Propylparaben, Sodium Hydroxide, Stearic Acid, Stearyl
Alcohol, Tocopheryl Acetate, Water.
Call 1-877-212-1985 Mon-Fri
Dr. Fisscher
ULTRASOL
Sunscreen Lotion SPF45
Broad UVA and UVB protection
Dermatologist Recommended
SCIENCE INSIDETM SUPERIOR SUN TECHNOLOGY
VERY WATER RESISTANT
VERY SWEAT RESISTANT
NON GREASY
250 ML. 8.45 FL. OZ.
RECOMMENDED - SKIN CANCER FOUNDATION
FISCHER PHARMACEUTICALS LTD.
Manufactured by:
Fischer Pharmaceuticals Ltd.
Bnei Brak, Israel, 51553
Made in Israel
NO ANIMAL INGREDIENTS - NO ANIMAL TESTING
24m
Dr. Fischer - Tried and Tested

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 59886-339-55 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-d8ec-f424-e053-dadaa90a57ce | Dr. Fischer ULTRASOL Sport Sunscreen Lotion SPF45 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 59886-339-55 | UltrasolSport | 250 g in 1 BOTTLE, PLASTIC | LOTION | 250 | 6 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 6 | |
| Octinoxate | ACTIVE INGREDIENT | 4Y5P7MUD51 | 6 | |
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 6 | |
| Oxybenzone | ACTIVE INGREDIENT | 95OOS7VE0Y | 6 | |
| Avobenzone | ACTIVE MOIETY | G63QQF2NOX | 6 | |
| Octinoxate | ACTIVE MOIETY | 4Y5P7MUD51 | 6 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 6 | |
| Oxybenzone | ACTIVE MOIETY | 95OOS7VE0Y | 6 | |
| ALPHA-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 6 | |
| Butylparaben | INACTIVE INGREDIENT | 3QPI1U3FV8 | 6 | |
| Chlorphenesin | INACTIVE INGREDIENT | I670DAL4SZ | 6 | |
| EDETATE DISODIUM | INACTIVE INGREDIENT | 7FLD91C86K | 6 | |
| Ethylparaben | INACTIVE INGREDIENT | 14255EXE39 | 6 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 6 | |
| Isopropyl Myristate | INACTIVE INGREDIENT | 0RE8K4LNJS | 6 | |
| Methylparaben | INACTIVE INGREDIENT | A2I8C7HI9T | 6 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 6 | |
| Propylene Glycol | INACTIVE INGREDIENT | 6DC9Q167V3 | 6 | |
| Propylparaben | INACTIVE INGREDIENT | Z8IX2SC1OH | 6 | |
| Sodium Hydroxide | INACTIVE INGREDIENT | 55X04QC32I | 6 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 6 | |
| Stearyl Alcohol | INACTIVE INGREDIENT | 2KR89I4H1Y | 6 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59886-339 | 59886-339-55 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Avobenzone | G63QQF2NOX | ACTIB |
| Octinoxate | 4Y5P7MUD51 | ACTIB |
| Octisalate | 4X49Y0596W | ACTIB |
| Oxybenzone | 95OOS7VE0Y | ACTIB |
| Butylparaben | 3QPI1U3FV8 | IACT |
| Chlorphenesin | I670DAL4SZ | IACT |
| EDETATE DISODIUM | 7FLD91C86K | IACT |
| Ethylparaben | 14255EXE39 | IACT |
| GLYCERYL MONOSTEARATE | 230OU9XXE4 | IACT |
| Isopropyl Myristate | 0RE8K4LNJS | IACT |
| Methylparaben | A2I8C7HI9T | IACT |
| Phenoxyethanol | HIE492ZZ3T | IACT |
| Propylene Glycol | 6DC9Q167V3 | IACT |
| Propylparaben | Z8IX2SC1OH | IACT |
| Sodium Hydroxide | 55X04QC32I | IACT |
| Stearic Acid | 4ELV7Z65AP | IACT |
| Stearyl Alcohol | 2KR89I4H1Y | IACT |
| ALPHA-TOCOPHEROL ACETATE | 9E8X80D2L0 | IACT |
| Water | 059QF0KO0R | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SUPPOSITORY / VAGINAL | 252 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | CREAM / VAGINAL | 3 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | EMULSION / TOPICAL | 0.11 %w/w | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION / ORAL | 400 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | TABLET / ORAL | 0.2 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / PERIDURAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRAMUSCULAR | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | EMULSION / ORAL | ADJ PH | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET / SUBLINGUAL | 9 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | ELIXIR / ORAL | 800 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SOLUTION / RESPIRATORY (INHALATION) | 43 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION / AURICULAR (OTIC) | 56.55 %w/v | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE, EXTENDED RELEASE / ORAL | 0.22 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | CAPSULE / ORAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | TABLET, DELAYED RELEASE / ORAL | 100 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SWAB / TOPICAL | 34.6 %w/w | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | POWDER, FOR SOLUTION / ORAL | 13 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, POWDER, FOR SOLUTION / INTRATUMOR | ADJ PH | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | SOLUTION, CONCENTRATE / ORAL | 2590 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | JELLY / NASAL | 250 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRA-ARTICULAR | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | SHAMPOO / TOPICAL | 1 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, POWDER, FOR SUSPENSION / INTRAVENOUS | 0.4 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CREAM / TOPICAL | 76000 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | GEL / VAGINAL | 20 mg | ||
| Stearyl Alcohol | STEARYL ALCOHOL | 2KR89I4H1Y | POWDER / ORAL | 0.11 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET, CHEWABLE / ORAL | 1 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / AURICULAR (OTIC) | NA | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | JELLY / TOPICAL | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRASPINAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | LIQUID / INTRAVENOUS | 0.03 %w/v | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | OINTMENT / TOPICAL | 29 mg | ||
| Propylparaben | PROPYLPARABEN | Z8IX2SC1OH | SUPPOSITORY / VAGINAL | NA | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SHAMPOO / TOPICAL | 0.15 %w/w | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | GEL / TRANSDERMAL | 1 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION/ DROPS / OPHTHALMIC | ADJ PH | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / VAGINAL | 140 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | TABLET, CHEWABLE / ORAL | 1.28 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / SUBCUTANEOUS | 22 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | SOLUTION / RECTAL | 0.13 %w/v | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | TABLET, FILM COATED / ORAL | 96 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION, SUSPENSION / SOFT TISSUE | ADJ PH | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | POWDER, FOR SOLUTION / ORAL | ADJ PH | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / INTRA-ARTERIAL | 176 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRADERMAL | ADJ PH | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SOLUTION / SUBCUTANEOUS | 2 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | INJECTION / DENTAL | ADJ PH | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | CAPSULE, EXTENDED RELEASE / ORAL | 2 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 5.4 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | OINTMENT / OPHTHALMIC | 0.05 %w/w | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / PARENTERAL | 18 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, COATED / ORAL | 42.4 mg | ||
| Methylparaben | METHYLPARABEN | A2I8C7HI9T | INJECTION / EPIDURAL | 1 mg | ||
| EDETATE DISODIUM | EDETATE DISODIUM | 7FLD91C86K | INJECTION, SUSPENSION / INTRAMUSCULAR | 1 mg | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SPRAY, METERED / NASAL | ADJ PH | ||
| Isopropyl Myristate | ISOPROPYL MYRISTATE | 0RE8K4LNJS | CREAM / TOPICAL | 65000 mg | ||
| Propylene Glycol | PROPYLENE GLYCOL | 6DC9Q167V3 | LIQUID / RESPIRATORY (INHALATION) | 10 %w/w | ||
| Sodium Hydroxide | SODIUM HYDROXIDE | 55X04QC32I | SOLUTION / INTRA-ARTERIAL | ADJ PH |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| b598d15e-72c4-4598-80a3-ff052b6fb494 | 3059ffac-c12e-49c7-b0e6-2af35217f3e5 | 2010-04-21 | Warnings | b598d15e-72c4-4598-80a3-ff052b6fb494 3059ffac-c12e-49c7-b0e6-2af35217f3e5 |
Adverse event summaries are temporarily unavailable. Other product information remains available.